The dynamic interplay of host and viral enzymes in type III CRISPR-mediated cyclic nucleotide signalling

Januka Sahan Athukoralage, Shirley Graham, Christophe Rouillon, Sabine Gruschow, Clarissa M Czekster, Malcolm White

Research output: Contribution to journalArticlepeer-review

36 Citations (Scopus)

Abstract

Cyclic nucleotide second messengers are increasingly implicated in prokaryotic anti-viral defence systems. Type III CRISPR systems synthesise cyclic oligoadenylate (cOA) upon detecting foreign RNA, activating ancillary nucleases that can be toxic to cells, necessitating mechanisms to remove cOA in systems that operate via immunity rather than abortive infection. Previously, we demonstrated that the Sulfolobus solfataricus type III-D CRISPR complex generates cyclic tetra-adenylate (cA4), activating the ribonuclease Csx1, and showed that subsequent RNA cleavage and dissociation acts as an ‘off-switch’ for the cyclase activity. Subsequently, we identified the cellular ring nuclease Crn1, which slowly degrades cA4 to reset the system (Rouillon et al., 2018), and demonstrated that viruses can subvert type III CRISPR immunity by means of a potent anti-CRISPR ring nuclease variant AcrIII-1. Here, we present a comprehensive analysis of the dynamic interplay between these enzymes, governing cyclic nucleotide levels and infection outcomes in virus-host conflict.
Original languageEnglish
Article numbere55852
Number of pages16
JournaleLife
Volume9
DOIs
Publication statusPublished - 27 Apr 2020

Fingerprint

Dive into the research topics of 'The dynamic interplay of host and viral enzymes in type III CRISPR-mediated cyclic nucleotide signalling'. Together they form a unique fingerprint.

Cite this